The Indian Pharmaceutical Alliance (IPA) represents research-based National Pharmaceutical Companies.
New labelling norms: Drug companies to have larger fonts for generic names.
Pharma companies may revise the prices of scheduled formulations by 3.422% w.e.f. 1st April 2018.
Poke Me: How policymakers killed off a once-thriving sector of India's much-vaunted pharma industry.
Increasing the period of surveillance data may delay entry of generic drugs.
The United Nations Secretary-General's High-Level Panel on Access to Medicines report- Promoting innovation and access to health technologies.
